Medical Affairs – Scientific Accountability and Professional Exchange
Contents
What is Medical Affairs?
Medical Affairs is the medical and scientific function that connects evidence, professional exchange and medical information needs within a company. Responsibilities may include medical strategy, information services, publications and collaboration with external experts.
Organizational structures vary. Professional accountability and clear boundaries around commercial promotion are essential. Medical Affairs is therefore not simply another name for marketing or sales.
Why does Medical Affairs matter to pharmaceutical organizations?
A medicine raises scientific questions throughout its lifecycle. Professionals need understandable information, while companies need to identify unanswered questions and evidence gaps. Medical Affairs can organize this exchange through appropriate scientific processes.
The function is also an important internal partner when interpreting studies or assessing medical statements. Collaboration with marketing may be necessary, but roles, decision routes and the purpose of each communication must remain clear. A shared topic does not mean that all functions should use the same objectives or evaluation criteria.
Which activities are particularly relevant?
Medical planning should follow scientific and healthcare questions.
- Interpret evidence: Assess study findings, limitations and outstanding questions in the relevant medical context.
- Support exchange: Respond through appropriate medical channels and organize professional feedback.
- Communicate knowledge: Support scientific publications and suitable educational or information activities.
- Manage interfaces: Collaborate with clinical development, safety functions and market access around defined questions.
The information that may be provided depends on product status, the occasion, the audience and applicable requirements. These conditions should be assessed for the activity rather than inferred solely from its department owner.
What challenges arise between functions?
Unclear objectives can cause medical activities to be managed as commercial contact programs. Organizations should define outcomes appropriate to each responsibility. Contact counts alone do not demonstrate scientific value or quality.
Insights from external discussions also need careful handling. Scientific learning should be distinguished from personal profiling and promotional conclusions. Medical inquiries and safety reports each require their designated workflow. Organizational placement by itself does not determine the legal classification of a particular communication.
Which medical team handles which task?
Medical Information responds to specific medical enquiries. Field Medical teams and MSLs conduct scientific discussions within their remit. Medical strategy brings together recurring questions and evidence gaps for further planning. Organizational arrangements vary. Effective handovers ensure an enquiry receives a qualified response and safety information reaches pharmacovigilance.
Conclusion: Connect evidence with scientific dialogue
Medical Affairs supports responsible use of medical knowledge. Clear roles, qualified people and traceable processes enable useful collaboration with other functions. Maintaining the distinction between scientific purpose and promotional objectives is central to pharmaceutical communication.
